Position in DXCM
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,459,070
+$267,378 QoQ
Shares Held
21,664
+14.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#424
of 966 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Tema ETFs LLC holds $13,771,329 across 8 Medical Devices names. DXCM ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
52,068 | $4,724,650 | |
| 2 | SYK |
Stryker Corp
|
7,306 | $2,300,221 | |
| 3 | BSX |
Boston Scientific Corp
|
45,794 | $1,954,487 | |
| 4 | EW |
Edwards Lifesciences Corp
|
19,353 | $1,750,672 | |
| 5 | DXCM |
Dexcom Inc
This page
|
21,664 | $1,459,070 | |
| 6 | PODD |
Insulet Corp
|
4,147 | $631,380 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
9,214 | $589,788 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
4,194 | $361,061 |
All Filings in DXCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,459,070 | 21,664 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,191,692 | 18,976 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,003,381 | 15,118 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $955,854 | 14,205 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $995,193 | 11,401 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,042,856 | 15,271 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,227,566 | 28,643 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||